The Food and Drug Administration (FDA) has turned its attention to Novo Nordisks splashy oral Wegovy campaign, just one month after the weight loss pill launched in the U.S
But, Semaglutide intervenes in this process
With proven GLP-1 therapy, expert guidance, and home delivery, MEDVi makes fat loss manageable, measurable, and real
On April 30, 2026, the FDA published a proposed rule (Federal Register docket 2026-08552) proposing to permanently exclude semaglutide, tirzepatide, and liraglutide from the list of bulk drug substances that 503B outsourcing facilities - large-scale compounding operations - are permitted to use
At the translational clinical level, L-carnitine primarily targets hepatic steatosisthe earliest pathological step in MASLD